Mostrar el registro sencillo del ítem

dc.contributor.author
Cho, Sang Soo  
dc.contributor.author
Strafella, Antonio P.  
dc.contributor.author
Duff Canning, Sarah  
dc.contributor.author
Zurowski, Mateusz  
dc.contributor.author
Vijverman, Anne Catherine  
dc.contributor.author
Bruno, Veronica Andrea  
dc.contributor.author
Aquino, Camila C.  
dc.contributor.author
Criaud, Marion  
dc.contributor.author
Rusjan, Pablo M.  
dc.contributor.author
Houle, Sylvain  
dc.contributor.author
Fox, Susan H.  
dc.date.available
2018-04-06T17:44:16Z  
dc.date.issued
2017-09  
dc.identifier.citation
Cho, Sang Soo; Strafella, Antonio P.; Duff Canning, Sarah; Zurowski, Mateusz; Vijverman, Anne Catherine; et al.; The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations; Wiley; Movement Disorders Clinical Practice; 4; 5; 9-2017; 698-709  
dc.identifier.issn
2330-1619  
dc.identifier.uri
http://hdl.handle.net/11336/41170  
dc.description.abstract
Background: There is growing evidence that the serotonergic system, in particular serotonin 2A receptors, is involved in neuropsychiatric symptoms in Parkinson's disease (PD), including cognitive processing and visual hallucinations. However, the relationship between serotonin 2A receptor availability, visual hallucinations, and cognitive profile is unknown. The objective of this study was to investigate the level of serotonin 2A receptor availability in brain regions affected by visual hallucinations and to test the association with cognitive/behavioral changes in patients who have PD with visual hallucinations. Methods: Nondemented patients who had PD with (n = 11) and without (n = 8) visual hallucinations and age‐matched controls (n = 10) were recruited. All participants completed neuropsychological testing, which consisted of visuoperceptual, executive, memory, language, and frontal‐behavioral function. Positron emission tomography scans using [18F]setoperone, a serotonin 2A antagonist radioligand, were acquired in patients with PD, and a parametric binding potential map of [18F]setoperone was calculated with the simplified reference tissue model using the cerebellum as a reference. Results: Patients who had PD with visual hallucinations exhibited significantly lower scores on measures of executive and visuoperceptual functions compared with age‐matched controls. These changes were paralleled by decreased [18F]setoperone binding in the right insula, bilateral dorsolateral prefrontal cortex, right orbitofrontal cortex, right middle temporal gyrus, and right fusiform gyrus. The psychometric correlation analysis revealed significant relationships among tests associated with visuoperceptual function, memory and learning, and serotonin 2A binding in different prefrontal and ventral visual stream regions. There was also reduced serotonin 2A receptor binding in patients who had PD with depression. Conclusions: These findings support a complex interaction between serotonin 2A receptor function and cognitive processing in patients who have PD with visual hallucinations.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Wiley  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
Alucinaciones  
dc.subject
Deterioro Cognitivo  
dc.subject
Parkinson  
dc.subject.classification
Otras Biotecnologías de la Salud  
dc.subject.classification
Biotecnología de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
The Relationship Between Serotonin-2A Receptor and Cognitive Functions in Nondemented Parkinson's Disease Patients with Visual Hallucinations  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2018-04-06T13:56:15Z  
dc.journal.volume
4  
dc.journal.number
5  
dc.journal.pagination
698-709  
dc.journal.pais
Estados Unidos  
dc.journal.ciudad
Hoboken  
dc.description.fil
Fil: Cho, Sang Soo. University of Toronto; Canadá  
dc.description.fil
Fil: Strafella, Antonio P.. University of Toronto; Canadá  
dc.description.fil
Fil: Duff Canning, Sarah. University of Toronto; Canadá  
dc.description.fil
Fil: Zurowski, Mateusz. University of Toronto; Canadá  
dc.description.fil
Fil: Vijverman, Anne Catherine. Onze‐Lieve‐Vrouw Hospital; Bélgica  
dc.description.fil
Fil: Bruno, Veronica Andrea. University of Toronto; Canadá. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Aquino, Camila C.. University of Toronto; Canadá  
dc.description.fil
Fil: Criaud, Marion. University of Toronto; Canadá  
dc.description.fil
Fil: Rusjan, Pablo M.. University of Toronto; Canadá  
dc.description.fil
Fil: Houle, Sylvain. University of Toronto; Canadá  
dc.description.fil
Fil: Fox, Susan H.. University of Toronto; Canadá  
dc.journal.title
Movement Disorders Clinical Practice  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://onlinelibrary.wiley.com/doi/abs/10.1002/mdc3.12466  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.1002/mdc3.12466